BRIEF-Regeneron pharmaceuticals says appeals court grants stay of permanent injunction for praluent
February 08, 2017 at 17:37 PM EST
* Regeneron Pharmaceuticals Inc says appeals court grants stay of permanent injunction for praluent (alirocumab) during appeals process
